1. Adelaide Research & Scholarship

Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 21-30 of 200 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2018High baseline levels of tumor necrosis factor receptor 1 are associated with progression of kidney disease in Indigenous Australians with diabetes: the eGFR follow-up studyBarr, E.L.; Barzi, F.; Hughes, J.T.; Jerums, G.; Hoy, W.E.; O'Dea, K.; Jones, G.R.; Lawton, P.D.; Brown, A.D.; Thomas, M.; Ekinci, E.I.; Sinha, A.; Cass, A.; MacIsaac, R.J.; Maple-Brown, L.J.
2020Effect of vancomycin or daptomycin with vs without an antistaphylococcal β-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a randomized clinical trialTong, S.Y.C.; Lye, D.C.; Yahav, D.; Sud, A.; Robinson, J.O.; Nelson, J.; Archuleta, S.; Roberts, M.A.; Cass, A.; Paterson, D.L.; Foo, H.; Paul, M.; Guy, S.D.; Tramontana, A.R.; Walls, G.B.; McBride, S.; Bak, N.; Ghosh, N.; Rogers, B.A.; Ralph, A.P.; et al.
2003The bath-plug closure of anterior skull base cerebrospinal fluid leaksWormald, P.; McDonogh, M.
2005Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imagingCorti, R.; Fuster, V.; Fayad, Z.; Worthley, S.; Helft, G.; Chaplin, W.; Muntwyler, J.; Viles-Gonzalez, J.; Weinberger, J.; Smith, D.; Mizsei, G.; Badimon, J.
1997Randomized, comparative trial of 20 micrograms vs 40 micrograms Engerix B vaccine in hepatitis B vaccine non-respondersGoldwater, P.
2020A fixel-based analysis of micro- and macro-structural changes to white matter following adult traumatic brain injuryWallace, E.J.; Mathias, J.L.; Ward, L.; Fripp, J.; Rose, S.; Pannek, K.
2021Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancerSinghal, D.; Hahn, C.N.; Feurstein, S.; Wee, L.Y.A.; Moma, L.; Kutyna, M.M.; Chhetri, R.; Eshraghi, L.; Schreiber, A.W.; Feng, J.; Wang, P.P.-S.; Babic, M.; Parker, W.T.; Gao, S.; Moore, S.; Das, S.; Thomas, D.; Pattnaik, S.; Brown, A.L.; D'Andrea, R.J.; et al.
2020Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remissionPagani, I.S.; Dang, P.; Saunders, V.A.; Grose, R.; Shanmuganathan, N.; Kok, C.H.; Carne, L.; Rwodzi, Z.; Watts, S.; McLean, J.; Braley, J.; Altamura, H.; Yeung, D.T.; Branford, S.; Yong, A.S.M.; White, D.L.; Hughes, T.P.; Ross, D.M.
2016Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: A cohort studyPan, G.; Simpson, S.; van der Mei, I.; Charlesworth, J.C.; Lucas, R.; Ponsonby, A.L.; Zhou, Y.; Wu, F.; Taylor, B.V.; Dear, K.; Dwyer, T.; Blizzard, L.; Broadley, S.; Kilpatrick, T.; Williams, D.; Lechner-Scott, J.; Shaw, C.; Chapman, C.; Coulthard, A.; Valery, P.
2020Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trialHankey, G.J.; Hackett, M.L.; Almeida, O.P.; Flicker, L.; Mead, G.E.; Dennis, M.S.; Etherton-Beer, C.; Ford, A.H.; Billot, L.; Jan, S.; Lung, T.; Murray, V.; Lundström, E.; Anderson, C.S.; Herbert, R.; Carter, G.; Donnan, G.A.; Nguyen, H.T.; Gommans, J.; Yi, Q.; et al.

Discover